Skip to main content

Kindergarten Vaccination Rates Hold Steady

Kindergarten vaccination coverage rates for measles, mumps, and rubella vaccine (MMR); diphtheria, tetanus, and acellular pertussis vaccine (DTaP); and varicella vaccine each approached 95% in the United States, according to the latest data from the Centers for Disease Control and Prevention (CDC).
The CDC report included 2016 to 2017 MMR, DTaP, and varicella vaccination coverage submitted by immunization programs in 48 states and the District of Columbia. Oklahoma and Wyoming did not report data.
The median vaccination coverage across the nation for two doses of MMR was 94.0%. The median vaccination rate for the state-required number of doses of DTaP was 94.5%. The median vaccination coverage rate for two doses of varicella vaccine was 93.8%.
Ranee Seither, MPH, an epidemiologist at the CDC in Atlanta, Georgia, and colleagues report that four states (California, New York, North Dakota, and Tennessee) all experienced increases in coverage of at least 1.5 percentage points for all reported vaccines. The authors published their findings in the October 13 issue of Morbidity and Mortality Weekly Report.
Since the 2011 to 2012 school year, the mean kindergarten exemption rate for MMR vaccination has remained at or below 2%. At this time, "[t]he mean percentage of kindergartners with an exemption from one or more required vaccines...is 2.0%," the authors write. They note that the exemption rate varies a great deal from state to state.
The median percentage of kindergartners attending school during a grace period or provisional enrollment was 2%, which was the same percentage as in 2015 to 2016.

Kindergarten Vaccination

Experts consider kindergarten vaccination requirements to be an excellent way to ensure children are fully vaccinated with the recommended age-appropriate vaccines. Thus, in an effort to protect students and communities against vaccine-preventable diseases, many state and local school systems require that children be fully vaccinated when they enter kindergarten. School nurses and other school personnel work with federally funded immunization programs to assess vaccination coverage and exemption status of children enrolled in public and private kindergartens.
States vary with regard to their requirements for vaccination, data collection, and definitions of grace period and provisional enrollment. Most states, however, require vaccination coverage for MMR, DTaP, and varicella.
Thirty states shared local-level school vaccination coverage. These data revealed that vaccination coverage varied at the local level.
The authors note that the data collected in their study should allow immunization programs to focus on schools with lower vaccination coverage and higher exemption levels. It should also make it possible for schools to follow up with undervaccinated students in the hopes of protecting them from vaccine-preventable diseases.
The authors have disclosed no relevant financial relationships.
Morb Mortal Wkly Rep. Published online October 12, 2017. Full text

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...